Drug dosing study in children getting routine medicines
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study measures how children’s bodies handle medicines they are already prescribed as standard care. It may help doctors choose safer, more accurate doses for children in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be under 21 years old
- Be receiving an “understudied” medicine as part of your usual care
- Have your parent/guardian consent and your own assent (agreement) if required
- You will continue taking the medicine as prescribed by your caregiver
- You must be able to participate as indicated on the consent/assent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial measures how medicines behave in the body when they are used in children younger than 8 years for a reason or dose not listed on the official FDA label. It may help doctors choose safer, better doses for children in the future.
This trial measures how the study medicines move through the body and how they affect the child in the Pediatric Cardiac Intensive Care Unit. It may help doctors choose safer and better dosing for critically ill children.
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
This study follows children who take medicines to better understand what causes side effects. It also looks at family history and genetics to see who may be more likely to have an adverse reaction, and it checks findings using adults.
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
This study looks at how common TB medicines are absorbed, used, and cleared in children who are already taking treatment for tuberculosis. It may help doctors choose safer and more effective doses for children.
Hear when a new Pediatric ALL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.